Zhongzhu Healthcare Holding Co Ltd
600568
Company Profile
Business description
Zhongzhu Healthcare Holding Co Ltd produces and sells ophthalmic, antiviral, and anti-infective drugs in China. Its products include eye and nasal drops, injections, solid preparations, and other products. The product consists of Pearl Eye Drops, Sodium Cromolyn Eye Drops, Acyclovir Eye Drops, Hydroxybenzazole Hydrochloride Eye Drops, Acyclovir Dispersible Tablets, Gatifloxacin Tablets.
Contact
No. 1 Qinglu South Road
8th Floor, Building 5
Yanlord Marina Center
Zhuhai519020
CHNT: +86 7286402068
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,246
Stocks News & Analysis
stocks
Sales shine but broader macro outlook darkens for this ASX share
US stores are struggling, but our investment thesis hinges on the Australian rollout.
stocks
Chart of the Week: US equity market trading at an attractive discount
The latest from our Chief US Market Strategist.
stocks
Undervalued ASX share retains wide moat rating despite regulatory pressures
Proposed price regulation impacts our fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,168.90 | 43.80 | 0.48% |
| CAC 40 | 8,245.80 | 18.07 | -0.22% |
| DAX 40 | 23,806.99 | 273.64 | -1.14% |
| Dow JONES (US) | 48,185.80 | 275.88 | 0.58% |
| FTSE 100 | 10,603.48 | 5.40 | -0.05% |
| HKSE | 25,752.40 | 140.62 | -0.54% |
| NASDAQ | 22,822.42 | 187.42 | 0.83% |
| Nikkei 225 | 55,895.32 | 413.10 | -0.73% |
| NZX 50 Index | 13,283.60 | 9.79 | 0.07% |
| S&P 500 | 6,824.66 | 41.85 | 0.62% |
| S&P/ASX 200 | 8,973.20 | 57.80 | 0.65% |
| SSE Composite Index | 3,966.17 | 28.83 | -0.72% |